 |
|
 |
| Research, Select, & Monitor |
Sunday, January 26, 2020 1:15:11 AM ET |
|
|
|
|
|
|
Proteostasis Therapeutics, Inc. has an overall rank of 784 out of 6316 stocks based on 4 positive rankings and 2 negative rankings.
|
| Positive Rankings |
90 Day Gain
Proteostasis Therapeutics rank is 188 |
Oversold Stochastics
Proteostasis Therapeutics rank is 262 |
Up EPS Surprise
Proteostasis Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings. |
Low Put/Call
Proteostasis Therapeutics has a low Put/Call ratio of 0.20 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Proteostasis Therapeutics is ranked 581. |
| Negative Rankings |
10 Day Loss
Proteostasis Therapeutics rank is 328 |
High vPut/Call
Proteostasis Therapeutics has a high Put/Call ratio of 0.51 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Proteostasis Therapeutics is ranked 2051. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Past performance is not indicative of future results
StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.
|